BioCryst Pharmaceuticals, Inc. (BCRX) Posts Q4 Loss of 22c/Share

February 19, 2013 6:14 AM EST
Get Alerts BCRX Hot Sheet
Price: $5.95 -1.49%

EPS Growth %: +20.0%

Financial Fact:
Product sales: 0

Today's EPS Names:
PG, CFG, GE, More
Trade BCRX Now!
Join SI Premium – FREE
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) reported Q4 EPS of ($0.22), $0.06 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $4.1 million versus the consensus estimate of $4.02 million.

For earnings history and earnings-related data on BioCryst Pharmaceuticals, Inc. (BCRX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment